TR200903014A1 - Oral yolla dağılan dimebolin bileşimleri. - Google Patents

Oral yolla dağılan dimebolin bileşimleri.

Info

Publication number
TR200903014A1
TR200903014A1 TR2009/03014A TR200903014A TR200903014A1 TR 200903014 A1 TR200903014 A1 TR 200903014A1 TR 2009/03014 A TR2009/03014 A TR 2009/03014A TR 200903014 A TR200903014 A TR 200903014A TR 200903014 A1 TR200903014 A1 TR 200903014A1
Authority
TR
Turkey
Prior art keywords
dimebolin
compounds
orally
orally dispersed
dispersed
Prior art date
Application number
TR2009/03014A
Other languages
English (en)
Inventor
Toksöz Ahmet
Çi̇fter Ümi̇t
Türkyilmaz Ali̇
Original Assignee
Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San. Ve Ti̇c. A.Ş. filed Critical Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority to TR2009/03014A priority Critical patent/TR200903014A1/tr
Priority to EP10160229A priority patent/EP2243468A1/en
Publication of TR200903014A1 publication Critical patent/TR200903014A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluşla bir ya da daha fazla farmasotik olarak kabul edilebilir eksipiyan ile birlikte dımebolin ya da bunun farmasotik olarak kabul edilebilir bir tuzunu içeren, oral yolla dağılan bir bileşim sağlanmıştır.
TR2009/03014A 2009-04-17 2009-04-17 Oral yolla dağılan dimebolin bileşimleri. TR200903014A1 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/03014A TR200903014A1 (tr) 2009-04-17 2009-04-17 Oral yolla dağılan dimebolin bileşimleri.
EP10160229A EP2243468A1 (en) 2009-04-17 2010-04-16 Orally Disintegrating Dimebolin Compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/03014A TR200903014A1 (tr) 2009-04-17 2009-04-17 Oral yolla dağılan dimebolin bileşimleri.

Publications (1)

Publication Number Publication Date
TR200903014A1 true TR200903014A1 (tr) 2010-11-22

Family

ID=41040745

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/03014A TR200903014A1 (tr) 2009-04-17 2009-04-17 Oral yolla dağılan dimebolin bileşimleri.

Country Status (2)

Country Link
EP (1) EP2243468A1 (tr)
TR (1) TR200903014A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110337290A (zh) 2016-12-31 2019-10-15 比奥克斯塞尔医疗股份有限公司 舌下右旋美托咪啶用于治疗激越的用途
AU2019295699A1 (en) 2018-06-27 2021-01-28 Arx, Llc Film formulations containing dexmedetomidine and methods of producing them
JP2022540706A (ja) 2019-07-19 2022-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
JP2024507991A (ja) * 2021-02-26 2024-02-21 バイオエクセル セラピューティクス，インコーポレイテッド 激越を処置するための方法及び組成物
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914818A1 (en) * 1996-06-14 1999-05-12 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
WO2008069963A1 (en) * 2006-12-01 2008-06-12 Medivation Neurology, Inc. Means for improving cognitive functions and memory based on hydrogenated pyrido (4,3-b) indoles (variants), pharmacological means based thereon and method for the use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2106864C1 (ru) 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера
RU2283108C2 (ru) 2003-12-08 2006-09-10 Сергей Олегович Бачурин ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914818A1 (en) * 1996-06-14 1999-05-12 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
WO2008069963A1 (en) * 2006-12-01 2008-06-12 Medivation Neurology, Inc. Means for improving cognitive functions and memory based on hydrogenated pyrido (4,3-b) indoles (variants), pharmacological means based thereon and method for the use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOEL HONEY; RAI PARSHURAM; RANA VIKAS; TIWARY ASHOK K: "Orally disintegrating systems: innovations in formulation and technology.", vol. 2, 2008, RECENT PATENTS ON DRUG DELIVERY & FORMULATION 2008, VOL. 2, NR. 3, PAGE(S) 258 - 274, ISSN: 1872-2113, pages: 258 - 274, XP002545408 *
ON BEHALF OF THE DIMEBON INVESTIGATORS; DOODY R S; GAVRILOVA S I; SANO M; THOMAS R G; AISEN P S; BACHURIN S O; SEELY L; HUNG D: "Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 372, no. 9634, 19 July 2008 (2008-07-19), pages 207 - 215, XP022938806, ISSN: 0140-6736, [retrieved on 20080717] *
PFISTER W R; GHOSH T K: "ORALLY DISINTEGRATING TABLETS PRODUCTS, TECHNOLOGIES, AND DEVELOPMENT ISSUES", PHARMACEUTICAL TECHNOLOGY, ADVANSTAR COMMUNICATIONS,INC, US, vol. 29, no. 10, 1 October 2005 (2005-10-01), pages 136 - 150, XP009066503, ISSN: 1543-2521 *

Also Published As

Publication number Publication date
EP2243468A1 (en) 2010-10-27

Similar Documents

Publication Publication Date Title
DK2077729T3 (da) Orale probiotiske doseringsformer
BRPI1012892A2 (pt) composto, e, composição farmacêutica.
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
BRPI1008498A2 (pt) Composto, prodroga do composto, medicamento, e, uso de um composto.
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI0914802A2 (pt) Composto, pró-droga, medicamento, uso do composto ou uma pró-droga de mesmo.
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
BRPI0820861A2 (pt) Comprimido oral dispersível
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
EA201070786A1 (ru) Бензофуропиримидиноны
WO2010102071A8 (en) Sustained release oral dosage forms of an r-baclofen prodrug
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
EA201001710A2 (ru) Фармацевтическая композиция, которая содержит соль стронция, витамин d и циклодекстрин
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BRPI1009757A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI0812234A2 (pt) Composto de quinolona e composição farmacêutica.